From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

from FDA

The U.S. Food and Drug Administration approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063